Endothelin receptor antagonist BQ-123 ameliorates myocardial ischemic-reperfusion injury in rats: A hemodynamic, biochemical, histopathological and electron microscopic evidence

Biomedicine and Pharmacotherapy

Volumn 64, Issue 9, 2010, Pages 639-646

  Goyal, S N ^a   Bharti, S ^a   Arora, S ^a   Golechha, M ^a   Arya, D S ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

BQ 123; Endothelin; Ischemia reperfusion injury; Myocardial infarction; Oxidative stress

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDITIS; CONTROLLED STUDY; ELECTRON MICROSCOPY; HEART EDEMA; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; HEMODYNAMIC MONITORING; HISTOPATHOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MORTALITY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ANTIOXIDANTS; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; HEMODYNAMICS; MALE; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATIVE STRESS; PEPTIDES, CYCLIC; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; VENTRICULAR FUNCTION, LEFT;

EID: 78049287600     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.06.001     Document Type: Article

References (36)

1. Jennings R.B., Reimer K.A. The cell biology of acute myocardial ischemia. Annu Rev Med 1991, 42:225-246.
2. Mohanty I.R., Arya D.S., Gupta S.K. Withania somnifera provides cardioprotection and attenuates ischemia-reperfusion induced apoptosis. Clin Nutr 2008, 27:635-642.
3. Grover G.J., Sleph P.G., Fox M., et al. Role of endothelin-1 and big endothelin-1 in modulating coronary vascular tone, contractile function and severity of ischemia in rat hearts. J Pharmacol Exp Ther 1992, 263:1074-1082.
4. Imaizumi T., Nejima J., Kiuchi K., et al. Dynamics and source of endothelin-1 and interleukin-6 following coronary reperfusion in patients with acute myocardial infarction. J Nippon Med Sch 2007, 74:131-147.
5. Ozdemir R., Parlakpinar H., Polat A., et al. Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury. Toxicology 2006, 219:142-149.
6. Li X.S., Wang Q.D., Pernow J. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischemia/reperfusion in the rat. Eur J Pharmacol 1995, 283:161-168.
7. Qiu S., Theroux P., Marcil M., et al. Plasma endothelin-1 levels in stable and unstable angina. Cardiology 1993, 82:12-18.
8. Rubanyi G.M., Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994, 46:325-415.
9. Douglas S.A., Elliott J.D., Ohlstein E.H. Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anesthized rat: effect of BQ-123 on systemic haemodynamic responses. Eur J Pharmacol 1992, 221:315-324.
10. Wainwright C.L., McCabe C., Kane K.A. Endothelin and the ischaemic heart. Curr Vasc Pharmacol 2005, 3:333-341.
11. Richard V., Kaeffer N., Hogie M., et al. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist. Br J Pharmacol 1994, 113:869-876.
12. Gonon A.T., Wang Q.D., Shimizu M., et al. The novel non-peptide selective endothelin A receptor antagonist LU 135,252 protects against myocardial ischaemic and reperfusion injury in the pig. Acta Physiol Scand 1998, 163:131-137.
13. Krause S.M., Lynch J.J., Stabilito I.I., et al. Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischaemic injury following acute coronary artery occlusion in the dog. Cardiovasc Res 1994, 28:1672-1678.
14. McMurdo L., Thiemermann C., Vane J.R. The effects of the endothelin ETA receptor antagonist. FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion. Br J Pharmacol 1994, 112:75-80.
15. Masaki T. Historical review: endothelin. Trends Pharmacol Sci 2004, 25:219-224.
16. Grover G.J., Dzwonczyk S., Parham C.S. The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res 1993, 27:1613-1618.
17. B receptor and nitric oxide synthase blockade induce BQ-123 sensitive pressor effects in the rabbit. Hypertension 1997, 30:1204-1209.
18. Ohkawa H., Oohishi N., Yagi N. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
19. Moron M.S., Depierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochem Biophy Acta 1979, 582:67-78.
20. Cabaud P., Wroblewski F. Colorimetric measurement of lactic dehydrogenase activity of body fluid. Am J Clin Pathol 1958, 30:234-236.
21. Aebi H, Catalase. In: Bergmeyer, H.U.(Ed.) Methods of enzymatic analysis. Academic Press Inc 1974:673-85.
22. Marklund S., Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974, 47:469-474.
23. Bradford M.M. A rapid and sensitive method for quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
24. Singh A.D., Amit S., Kumar O.S., et al. Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats. Basic Clin Pharmacol Toxicol 2006, 98:604-610.
25. Loh H.K., Sahoo K.C., Kishore K., et al. Effects of thalidomide on isoprenaline-induced acute myocardial injury: a haemodynamic, histopathological and ultrastructural study. Basic Clin Pharmacol Toxicol 2007, 100:233-239.
26. Garjani A., Wainwright C.L., Zeitlin I.J., et al. Effects of endothelin-1 and the ETA-receptor antagonist BQ123, on ischaemic arrhythmias in anaesthetised rats. J Cardiovasc Pharmacol 1995, 25:634-642.
27. Cernacek P., Steward D.J., Monge J.C., et al. The endothelin system and its role in acute myocardial infarction. Can J Physiol Pharmacol 2003, 81:598-606.
28. Cernacek P., Tanguay J.F., Ducharme A., et al. Endothelin ETA receptor blockade during peri-infarction period in the rat. Can J Cardiol 2001, 17:174.
29. Wang Q.D., Uriuda Y., Pemow J., et al. Myocardial release of endothelin (ET) and enhanced ET, receptor mediated coronary vasoconstriction following coronary thrombosis and thrombolysis in the pig. J Cardiovasc Pharmacol 1995, 26:770-776.
30. Watanabe T., Suzuki N., Shimamoto N., et al. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 1991, 69:370-377.
31. Omland T., Lie R.T., Aakvaag A., et al. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 1994, 89:1573-1579.
32. Vitola J.V., Forman M.B., Holsinger J.P., et al. Role of endothelin in a rabbit model of acute myocardial infarction: effects of receptor antagonists. J Cardiovasc Pharmacol 1996, 28:774-783.
33. Arya D.S., Bansal P., Ojha S.K., et al. Pyruvate provides cardioprotection in the experimental model of myocardial ischemic reperfusion injury. Life Sci 2006, 79:38-44.
34. Hong X.U., Li L.I.N., Wen-Jun Y. Antiarrhytmic effect of endothelin-A receptor antagonist on acute ischemic arrhythmia in isolated rat heart. Acta Pharmacol Sin 2003, 24:37-44.
35. Shlafer M., Kane P.F., Kirsh M.M. Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart. J Thorac Cardiovasc Surg 1982, 83:830-839.
36. Tsao P.S., Oki N., Lefer D.J., et al. Time course of endothelial dysfunction and myocardial injury during ischemia-reperfusion in the cat. Circulation 1990, 82:1402-1412.